Lyric Bio Inc: Valuation, Funding & Investors
Lyric Bio, Inc. is a next-generation biomanufacturing startup developing human-tissue-based production systems for donor-derived therapeutics. The company is dedicated to building next-generation manufacturing for donor-derived and protein-based therapeutics, with an initial focus on immunoglobulin production.
Leadership & Board
- Current Number of Employees
- 14
- Current LinkedIn Followers
- 1,215
Latest Estimated Valuation
- Total Amount Raised
- $7M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $7M
- Latest Funding Round
- Seed Round
Employee Trend
Lyric Bio Inc had 14 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
14Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Lyric Bio Inc had 1,215 followers as of October 26, 2026. The number of followers increased by 0 (0.00%) week-over-week.
1,215Latest Followers Count
0(0.00%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 02, 2025 | Seed Round | $6.60M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| SOSV | Seed Round |
| Draper Associates | Seed Round |
| The Venture Collective | Seed Round |
| Black Diamond Ventures | Seed Round |
| Lucas Venture Group | Seed Round |
| Meiji Seika Pharma | Seed Round |
Similar Companies
A snapshot of private companies similar to Lyric Bio Inc, helping you discover and navigate related company profiles.
Related News and Analysis
